Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of August 2024. The report specifically details a transaction in the company's own shares executed on August 5, 2024, under a share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
| Metric | Value |
|---|---|
| Date of Purchase | August 5, 2024 |
| Number of Shares Purchased | 704,300 |
| Highest Price Paid per Share | 371.70 pence |
| Lowest Price Paid per Share | 365.80 pence |
| Volume Weighted Average Price | 369.1351 pence |
| Registered Share Capital Post-Settlement | 9,131,187,525 ordinary shares |
Material Changes
The primary material change reported is the reduction of the company's registered share capital following the cancellation of 704,300 ordinary shares. The filing does not provide comparative data against prior periods for financial performance.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of risks and contingencies. It serves as a regulatory disclosure of a specific capital transaction in compliance with the Market Abuse Regulation (EU) No 596/2014 as applied in the UK.
Key Facts for Investor Verification
- Verify the total number of shares repurchased under the August 2024 Buyback Programme to date.
- Confirm the updated total registered share capital of 9,131,187,525 shares for disclosure threshold calculations.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link for granular pricing data.
- Note that this filing does not contain financial performance results; refer to the most recent Form 20-F or quarterly earnings release for revenue and profit data.